Evaluating the Moderating Role of Anxiety Sensitivity on Smoking in Terms of Panic Psychopathology: by McLeish, Alison Christine
University of Vermont
ScholarWorks @ UVM
Graduate College Dissertations and Theses Dissertations and Theses
9-12-2007
Evaluating the Moderating Role of Anxiety




Follow this and additional works at: http://scholarworks.uvm.edu/graddis
This Dissertation is brought to you for free and open access by the Dissertations and Theses at ScholarWorks @ UVM. It has been accepted for
inclusion in Graduate College Dissertations and Theses by an authorized administrator of ScholarWorks @ UVM. For more information, please contact
donna.omalley@uvm.edu.
Recommended Citation
McLeish, Alison Christine, "Evaluating the Moderating Role of Anxiety Sensitivity on Smoking in Terms of Panic Psychopathology:"





EVALUATING THE MODERATING ROLE OF ANXIETY SENSITIVITY ON 
SMOKING IN TERMS OF PANIC PSYCHOPATHOLOGY:  
A PROSPECTIVE TEST AMONG DAILY SMOKERS 
 
 
A Dissertation Presented  
by  
Alison Christine McLeish 
to  
The Faculty of the Graduate College  
of  
The University of Vermont  
 
 
In Partial Fulfillment of the Requirements  
for the Degree of Doctor of Philosophy 










The aim of the present investigation was to evaluate the moderating role of the physical 
concerns domain of anxiety sensitivity (AS) in the relation between smoking rate and 
panic vulnerability variables, both concurrently and prospectively, among a community-
based sample of 125 daily smokers (60 females; Mage = 26.02 years, SD = 10.98). As 
hypothesized, there was a significant interaction between AS Physical Concerns and 
smoking rate in relation to agoraphobic avoidance, such that at higher levels of AS 
Physical Concerns and higher smoking rates, there was a risk for increased agoraphobic 
avoidance (3.6% unique variance). Contrary to prediction, however, the interaction 
between AS Physical Concerns and smoking rate did not significantly predict the 
tendency to catastrophize about bodily sensations, body vigilance, or lifetime history of 
panic attacks. In regard to the prospective analyses, there was a significant interaction 
between AS Physical Concerns and smoking rate in relation to Time 2 anticipatory 
anxiety, such that at higher levels of AS Physical Concerns and higher rates of smoking, 
there was a significant risk for an increase in anticipatory anxiety over the three-month 
follow-up period (5% unique variance). Contrary to prediction, the interaction between 
AS Physical Concerns and smoking rate did not significantly predict the occurrence of 
panic attacks during the three month follow-up period. The current findings suggest that 
daily smokers smoking at higher rates with high AS Physical Concerns may be more 
prone to engage in avoidance (Time 1 findings) and show increases in worry about 
potentially threatening events in the future (Time 2 anticipatory anxiety findings). This 
interaction appears to be relatively specific to only some aspects of panic-relevant 
vulnerability factors. This pattern of findings may be used to conceptually guide the 
refinement of etiological models of panic vulnerability that involve smoking behavior.  
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Anxiety disorders are among the most common classes of psychopathology. In the 
National Comorbidity Survey and National Comorbidity Survey Replication (Kessler et 
al., 1994; Kessler, Chiu, Demler, & Walters, 2005; Kessler, Berglund, Demler, Jin, & 
Walters, 2005), anxiety disorders were more common than any other major group of 
diagnoses (with the exception of substance use disorders) with a lifetime prevalence rate 
of 25%. Aside from a high prevalence rate, anxiety disorders generally maintain a 
chronic, fluctuating course (Pine, Cohen, Gurley, Brook, & Ma, 1998), resulting in 
substantial impairment across the lifespan (Ferdinand & Verhulst, 1995). For instance, 
one international study (Ormel et al., 1994) found more than half of patients with Panic 
Disorder (PD) reported moderate to severe occupational dysfunction and physical 
disability; the disability was similar to that of major depressive disorder and greater than 
that for alcohol dependence. In addition to human suffering, anxiety disorders place a 
large burden on the financial and social resources of society. According to one recent 
estimate, the economic cost of anxiety disorders in the United States exceeds $42 billion 
per year (Greenberg et al., 1999). Although there has been significant progress made in 
developing efficacious treatments for anxiety disorders among children and adults (e.g., 
Barlow, Gorman, Shear, & Woods, 2000), only a very small percentage of those in need 
of clinical services actually receive appropriate care [Institute of Medicine (IOM), 1989]. 
Interestingly, there have been very few attempts to develop and implement prevention 





the lack of understanding of what and how vulnerability processes impart risk for specific 
disorders (see Feldner, Zvolensky, & Schmidt, 2004, for an expanded discussion). 
Panic Disorder: Definition and Nature 
Panic Disorder is a debilitating disorder that affects approximately 1.7% of the 
adult U.S. population in any given year [National Institute of Mental Health (NIMH), 
1999] and has a lifetime prevalence rate of 1.5%-3.5% worldwide [American Psychiatric 
Association (APA), 2000; Kessler, et al., 1994]. Panic disorder is characterized by 
recurrent, unexpected panic attacks and anxious apprehension about the possibility of 
experiencing future panic episodes (Bouton, Mineka, & Barlow, 2001). The disorder 
often is complicated by agoraphobia that can limit social involvement and/or personal 
mobility (APA, 2000), other psychological disorders, and physical health problems 
(Brown, Antony, & Barlow, 1995). Panic Disorder is regarded as a disorder of adulthood 
with a median age of onset of 24 (Burke, Burke, Regier, & Rae, 1990). However, the 
distribution of the age of onset for PD is bimodal with peaks at 15-24 and 45-54 years of 
age (APA, 2000). Thus, both younger adults and middle-aged adults are at risk for 
developing panic attacks and panic disorder, suggesting extending examinations of 
emotional vulnerability for this problem to relatively wide age ranges. In the NIMH 
Epidemiological Catchment Area study, Regier, Burke, and Burke (1990) found that PD 
occurs twice as often in women than in men (2.1% vs. .9%). Similar results were found in 
the National Comorbidity Survey, where the prevalence of PD was 2.5 times as likely in 





Individuals with PD have one of the highest rates of service usage among the 
anxiety disorders (Greenberg et al., 1999). In fact, patients with PD may see as many as 
10 or more physicians and undergo numerous expensive and unnecessary procedures 
before being diagnosed with the disorder (NIMH, 1995). PD is also associated with 
financial problems; in one investigation, 60% of those with PD were unemployed and 
37% of men and 42% of women with PD received some sort of financial assistance (e.g., 
disability, welfare, unemployment; Leon, Portera, & Weissman, 1995). Despite the 
availability of efficacious treatments for PD, only 10-15% of individuals with the 
disorder receive empirically supported clinical services (Goisman et al., 1994). Moreover, 
there has been very little development in terms of preventive approaches for PD (APA, 
2000; Kessler, et al., 1994). 
It is noteworthy that a much larger percentage of the general population 
experience panic attacks without necessarily developing PD (Norton, Cox, & Malan, 
1992). Typically, individuals who experience these nonclinical panic attacks do not 
experience these attacks as “spontaneous” or “uncued” as is generally the case in PD, but 
rather in certain threat-based contexts such as stressful daily experiences or traumatic life 
events (Bernstein et al., 2005). In fact, panic attacks are relatively common human 
experience and readily occur across various clinical conditions (Barlow, Brown, & 
Craske, 1994). From at least a heuristic level, some scholars have suggested panic attacks 
can be conveniently conceptualized as falling along a continuum of severity with 
nonclinical panickers scoring between clinical panickers and non-panickers on most 





however, that such a theoretical model (i.e., implicitly dimensional) has not been tested 
empirically. Nonetheless, clinical and nonclinical panickers tend to use different coping 
strategies to manage their panic (see Feldner, Zvolensky, & Leen-Feldner, 2004, for a 
review) and this aspect has been discussed, albeit not extensively tested, as one critical 
self-regulation difference that may help explain differential risk for developing panic 
disorder (cf. nonclinical panic attacks). For instance, descriptive research suggests 
nonclinical panickers employ positive coping strategies such as relaxation exercises, 
while clinical panickers typically use avoidance and distraction as coping strategies (Cox, 
Endler, Swinson, & Norton, 1992). 
Theoretical Models of Panic Disorder Development  
Several theories have been developed that attempt to explain PD. Although these 
theories are not necessarily mutually exclusive, they each offer a different “point of 
entry” in attempting to understand the etiology of PD. Biological theories point to an 
overly sensitive suffocation alarm as an explanation for PD (Klein, 1993). In normal 
individuals, when the suffocation alarm is activated, a “fight or flight” response occurs 
and the individual experiences symptoms of breathlessness and the urge to flee. From an 
evolutionary perspective, this system is purported to be adaptive as it might allow 
humans to survive natural disasters and attacks by predators. However, individuals with a 
hypersensitive suffocation alarm are believed to experience numerous “false alarms” 
where these same symptoms are experienced in the absence of any threat. Feelings of 
breathlessness are often followed by over-breathing and acute fear, which in these 





purported to be elicited by slight fluctuations in levels of carbon dioxide, this theory may 
account for patients’ reports that their panic attacks seem to come “out of the blue.” 
Empirical evidence, however, has not supported this theory. For example, Gorman et al. 
(2001) found that individuals with Premenstrual Dysphoric Disorder experienced panic 
attacks in response to 5% and 7% CO2 inhalation at similar rates as individuals with PD. 
Thus, while individuals with PD experience greater levels of anxiety in response to CO2 
inhalation, it does not appear that this is necessarily due to specific physiological 
abnormalities. Moreover, a variety of other studies have found that suffocation-based 
fears (Eifert, Zvolensky, Sorrell, Hopko, & Lejuez, 1999; Taylor & Rachman, 1994) and 
changes in CO2 are not associated with fear response to biological challenge (Schmidt, 
Telch, & Jaimez, 1996). These sources of data do not support major theoretical 
predictions derived from the suffocation-oriented theory of PD, and by extension, cast 
doubt on the validity of such a perspective. 
Alternatively, Barlow (1991, 2002) and Bouton et al. (2001) posit that panic 
attacks are conditioning experiences that link anxiety and panic to both interoceptive and 
exteroceptive cues. This type of perspective represents a learning theory of PD 
development. Specifically, it is theorized that conditioned anxiety potentiates the next 
panic attack in a downward negative spiral that culminates in PD. In this context, these 
emotional events are not false alarms, but rather, learned alarms. The initial physical 
symptoms of a panic attack are associated with the later full blown panic attack. Thus, the 
individual becomes vigilant to slight fluctuations in physical functioning in order to 





unconditioned stimulus (US) and conditioned stimulus (CS), an index of 
“belongingness,” fairly robust conditioning is posited to occur. By avoiding situations 
that might elicit these interoceptive stimuli, the individual with PD prevents extinction of 
this conditioning. Although this learning theory perspective of PD development is a 
promising model for understanding PD, no empirical studies have been conducted to 
explicitly test this theory. There is, however, a variety of indirect evidence that would be 
consistent with this perspective, including that interoceptive-exteroceptive conditioning 
(e.g., fear response pairing with visually based internal stimuli such as heart rate) is 
quickly acquired and highly resistant to extinction (Forsyth & Eifert, 1996).  
Clark’s (1986) cognitive theory of PD conceptualizes panic as stemming from 
catastrophic misinterpretations of bodily sensations. Individuals with PD perceive normal 
physical sensations in response to anxiety (e.g., heart palpitations) as a signal of 
impending doom (e.g., having a heart attack). This misinterpretation causes a further 
increase in anxiety, which then produces more physical sensations in a vicious cycle 
ending in a panic attack. This holds true especially for ambiguous autonomic stimuli. In 
fact, PD patients have been found to misinterpret ambiguous physical sensations more so 
than those with other anxiety disorders and non-clinical controls (Clark et al., 1997). 
Moreover, individuals who fear their own anxiety symptoms (i.e., high in anxiety 
sensitivity) report catastrophic interpretation of ambiguous situations even prior to the 
experience of panic attacks, suggesting the existence of a panic self-schema (Teachman, 
2005). However, Rachman, Levitt, and Lopatka (1987) found that while panic episodes 





physical symptoms, there were also a significant number of “non-cognitive” panic 
episodes (e.g., nocturnal panic). The cognitive theory of PD is unable to explain these 
non-cognitive panic episodes. Moreover, this cognitive theory of PD has been criticized 
theoretically because it is potentially unfalsifiable, particularly as it was originally 
conceived (McNally, 1999a). 
Lastly, the Anxiety Sensitivity (AS) theory proposes that it is not the 
misinterpretation of bodily sensations per se, but fear of actual physical sensations that is 
the panicogenic process in PD development. AS is an individual difference variable that 
indexes a “fear of fear” or a fear of anxiety symptoms themselves. Individuals high in AS 
tend to believe that these physical sensations may cause serious physiological, 
psychological, or social consequences. For example, if a person perceives bodily 
sensations associated with autonomic arousal as a sign of imminent harm, this “high AS” 
individual will likely experience elevated levels of anxiety and be at an increased risk for 
panic. Moreover, this fear is posited to lead to avoidance of situations that would invoke 
these sensations (e.g., avoiding exercise). The AS theory has received a great deal of 
research attention in recent years with promising, independently replicated results. In 
fact, several prospective studies have shown that AS can predict later panic attacks and 
panic disorder (Schmidt, Lerew, & Jackson, 1997, 1999; Maller & Reiss, 1992) and that 
AS has exhibited greater specificity to panic than temperamental variables such as 
negative affectivity (Hayward, Killen, Kraemer, & Taylor, 2000). Extant research on AS 





 Together, theoretical models of PD generally converge on the role of 
interoceptive distress and fears of such bodily perturbation in the generation of panic-
related problems. Although naturally no one model can adequately account for all cases 
of PD development at the present time, there are some promising findings, particularly in 
regard to the AS theory. Nonetheless, it is noteworthy that none of the existing theories of 
PD development explicitly focus on the role of behavioral factors in panic etiology, and 
by extension, denote a specific role for behavioral factors in the disorder development. 
As will be discussed, this lack of focus on behavioral factors is striking given PD is 
highly associated with various types of addictive behaviors and that these behaviors 
typically precede the onset of panic attacks and PD (Zvolensky, Schmidt, & Stewart, 
2003). In some respects, this lack of scientific attention to drug-related problems in PD is 
representative of a larger issue in anxiety disorder research: a failure to recognize and 
systematically examine the role of substance use problems as specific vulnerability 
factors for anxiety psychopathology (Zvolensky & Schmidt, 2004).  
Risk Factors: Conceptual Clarification 
Before proceeding further into a discussion of substance use problems in PD 
etiology, it is important to first clarify what is meant by the term “risk.” Most of the 
important theoretical work in defining risk concepts in contemporary clinical science has 
originated from cutting-edge work in developmental psychopathology by Kazdin, 
Kraemer, and their colleagues. They have defined a risk factor as a “characteristic, 
experience, or event that, if present, is associated with an increase in the probability (risk) 





Like psychological disorders, risk factors are not typically best understood as static 
entities. The association between risk factor and outcome depends on characteristics of 
the population (age, sex), characteristics of the risk factor (duration, point in development 
when exposed), other variables associated with the risk factor, and characteristics of the 
outcome (Kazdin et al., 1997). In brief, risk factors are probabilistic in that they affect the 
likelihood of a certain outcome but do not determine the outcome. 
Risk factor research gives us an initial roadmap for identifying risk factors and a 
way to increase specificity in our theoretical models of the etiology of particular 
disorders. Kraemer et al. (1997) have conceptualized a hierarchy of influence of potential 
risk factors and outcomes (see Table 1). The first step in this progression is to determine 
whether or not there is an association between two characteristics. Next, temporal 
relations must be established in order to show that the characteristic is a risk factor for a 
particular outcome. Lastly, causality must be determined. A risk factor that is not causally 
involved in a disorder is deemed a “marker” and can be either variable or fixed – terms 
defined momentarily. If a risk factor is shown to influence the likelihood of the outcome 
when manipulated, then it can be considered a causal risk factor. For example, a great 
deal of recent research in the field of health psychology has attempted to elucidate the 
causes of obesity. One factor that has been highlighted as a potential cause of obesity is 
lack of exercise. In order to determine the nature of this association, studies would first 
have to show that lack of exercise and obesity are related, thus establishing them as 
correlates. The next step would be to determine whether or not lack of exercise preceded 





obesity and that obesity never preceded lack of exercise. If this is shown to be the case, 
then lack of exercise would be considered a risk factor for obesity. It would then be 
necessary to determine what type of a risk factor lack of exercise may represent. If 
research did not show that lack of exercise caused obesity, yet still preceded obesity, then 
it would be considered a marker for obesity. Since lack of exercise is malleable, it would 
be a variable marker. Had this marker been gender, a variable that is not malleable (i.e., 
changeable), it would be a fixed marker. If lack of exercise were found to be a variable 
marker, future research would need to examine other correlates of lack of exercise to find 
alternative pathways to obesity. If, on the other hand, changes in amount of exercise 
changed one’s risk for obesity, then exercise would be considered a causal risk factor for 
obesity. Although it is clear that exercise is not the only risk factor for obesity, it is one 
lifestyle variable that can be manipulated to decrease the likelihood of obesity. 
Collectively, this illustrative example highlights the importance and utility of explicating 
risk factor effects in terms of better understanding health-related problems. 
Smoking and Panic Disorder 
 As briefly mentioned in the above section, there has been a general lack of 
attention paid to the role of addictive behaviors generally, and cigarette smoking 
specifically, in anxiety disorders research. This lack of attention is striking and 
potentially of great clinical concern, as there are likely bi-directional negative effects for 
addictive behaviors to increase the risk of panic-related problems as well as the converse 
(see e.g., Kushner, Abrams, & Borchardt, 2000; Kushner, Sher, & Beitman, 1990; 





Schmidt, 2004; Zvolensky, Schmidt, & Stewart, 2003, for expanded discussions of this 
issue).  Before discussing bi-directional influences, however, it is perhaps useful to point 
out one illustrative example of the degree of lack of knowledge of drug problems among 
treatment specialists using one of the most common of the addictive drugs – 
tobacco/cigarette smoking. One study recently examined knowledge and perceived 
competence regarding smoking cessation among mental health professionals who 
specialize in the treatment of anxiety disorders (Zvolensky, Baker, et al., 2005). Results 
indicated that therapists assess smoking behavior in only about 30% of clients, perceive 
themselves as “definitely unprepared” to deliver smoking cessation treatment, and only a 
minority (18%) have received formal training in empirically-based smoking cessation 
practices. When benchmarked against primary care physicians, anxiety specialists 
illustrated deficits on “basic” cessation counseling practices (e.g., assess for smoking 
behavior). Clearly, these data underscore that it is critically important to increase our 
scientific knowledge of smoking-related processes and clinical attention to their role in 
panic psychopathology. 
 Co-occurrence of smoking and panic-related problems. Smoking remains one of 
the leading preventable causes of death and disability in the U.S., accounting for 440,000, 
or 1 in 5, deaths each year [Centers for Disease Control and Prevention (CDC), 2004]. A 
number of efforts have been made to understand the associations between smoking and 
specific types of mental illness. The vast majority of this research has focused on 
schizophrenia and depressive disorders (e.g., Ginsberg, Hall, Reus, & Muñoz, 1995; 





been devoted to the link between smoking and anxiety disorders. This lack of attention is 
unfortunate, as anxiety disorders co-occur with smoking at rates that exceed those found 
in the general non-psychiatric population and many other psychiatric conditions 
(Amering et al., 1999; Beckham et al., 1997; Degenhardt, Hall, & Lynskey, 2001; 
McCabe et al., 2004; Orlando, Ellickson, & Jinnett, 2001; Pohl, Yeragani, Balon, Lycaki, 
& McBride, 1992). For instance, Lasser and colleagues (2000) recently found that among 
4,000 respondents from the National Comorbidity Survey, current smoking rates for 
respondents with an anxiety disorder in the past month or lifetime were significantly 
greater than smoking rates among respondents with no mental illness. In this same study, 
reported rates of smoking among those with anxiety disorders were highest among 
individuals with panic-related problems (i.e., history of panic attacks and panic disorder) 
and other anxiety disorders where panic attacks are common (i.e., posttraumatic stress 
disorder and generalized anxiety disorder; Lasser et al., 2000). As a point of reference, 
the percentages of smoking among people with nonclinical panic attacks and panic 
disorder were greater than or equal to those found for major depressive disorder and 
dysthymia (Lasser et al., 2000). These studies also indicate that the observed associations 
between smoking and anxiety psychopathology are not due to sociodemographic 
characteristics (e.g., gender), other psychiatric conditions (e.g., major depressive 
disorder, alcohol dependence), or symptom overlap in diagnostic criteria for anxiety 
disorders and nicotine dependence (Zvolensky, Schmidt, & Stewart, 2003). In fact, a 
recent review found that, across all extant studies, the average rate of smoking among 





twice as prevalent among smokers compared to non-smokers (Zvolensky, Feldner, Leen-
Feldner, & McLeish, 2005). Other research indicates that a greater proportion of 
individuals with PD report smoking at higher rates than individuals with social phobia 
and obsessive-compulsive disorder (McCabe et al., 2004). These data suggest that 
individuals with PD are likely to be heavier smokers than persons with other anxiety 
disorders, and perhaps are more dependent on nicotine.1 
  Impact of Smoking on Panic-related Vulnerability. There are, of course, a 
number of possible bi-directional influences between smoking and panic processes and 
outcomes (e.g., predisposition models, pathoplastic models, spectrum models, scar 
models; Clark, Watson, & Mineka, 1994). Recent research has begun to elucidate that 
panic vulnerability factors such as AS and a history of panic attacks are associated with 
(1) increases in the chance of early lapse and subsequent relapse to smoking (Brown, 
Kahler, Zvolensky, Lejuez, & Ramsey, 2001; Zvolensky, Feldner, Eifert, & Brown, 
2001; Zvolensky, Lejuez, Kahler, & Brown, 2004); (2) heightened negative affect during 
quit attempts (Zvolensky, Baker et al., 2004; Zvolensky, Lejuez, et al., 2004; Zvolensky, 
Schmidt, et al., 2005); and (3) smoking principally aimed to reduce negative affect states 
(including withdrawal symptoms), but not for other motivational reasons (e.g., handling, 
taste; Comeau, Stewart, & Loba, 2001; Novak, Burgess, Clark, Zvolensky, & Brown, 
2003; Zvolensky, Feldner, et al., 2004; Zvolensky, Kotov, Antipova, & Schmidt, 2005). 
These data highlight the potentially important role of panic vulnerability factors in 





predisposition models; Clark et al., 1994). Yet, smoking also may be associated with 
increased risk of developing and/or exacerbating panic-related vulnerability. 
 Evidence has shown that smoking is associated with more severe panic problems 
(e.g., pathoplastic models; Clark et al., 1994). A number of studies have been completed 
in this domain. First, regular smokers with PD have been found to report more severe 
anxiety symptoms (especially anticipatory anxiety) and social impairment than non-
smokers with PD (McCabe et al., 2004; Zvolensky, Schmidt, & McCreary, 2003). These 
findings appear to be specific to PD as compared to anxiety disorders in general. A recent 
study by Morissette, Brown, Kamholz, & Gulliver (in press) found that smokers with 
anxiety disorders, as compared to their non-smoking counterparts, reported higher levels 
of AS (overall, mental, and physical concerns), negative affect, anxiety, and agoraphobic 
avoidance. However, this association appears to be due to the influence of panic disorder 
with agoraphobia (PDA); when looking at smokers and nonsmokers with any anxiety 
disorder other than PDA, no differences were found. Similar to previous findings, among 
those with PDA, smokers reported greater interoceptive sensitivity, anxiety sensitivity 
(overall, mental, and physical concerns), and life interference than nonsmokers. Second, a 
biological challenge study indicated that smokers with PD reported greater levels of 
anxiety and bodily distress than smokers without PD and than nonsmokers with PD 
(matched on comorbidity criteria) at the post-challenge assessment and recovery period, 
but no differences in autonomic responding during the challenge or in recovery 
(Zvolensky, Leen-Feldner et al., 2004). Also, in terms of rate of recovery, the linear 





PD than for smokers with PD. These data suggest smokers with PD are at risk for delayed 
anxiety-related recovery from panic-relevant bodily perturbation, and moreover, due to 
selection criteria, cannot be attributed to medical history or psychiatric comorbidity. 
Finally, another investigation explored panic-relevant cognitive processes in a sample of 
persons (n = 70) who met criteria for either (1) a positive nonclinical panic attack history 
and regular smoking (smoking at least 10 cigarettes per day for > 12 months; PASM), (2) 
a positive nonclinical panic attack history but no history of smoking (PA), or (3) regular 
smoking history alone (smoking at least 10 cigarettes per day for > 12 months; SM) 
(Zvolensky, Forsyth, Fuse, Feldner, & Leen-Feldner, 2002). PASM participants 
demonstrated significantly greater body vigilance and anxiety sensitivity mental 
incapacitation concerns compared to persons in either the PA or SM groups. The 
observed effects, again, could not be attributed to self-reported physical health status or 
history of medical problems. Although thus far restricted to a small number of cross-
sectional investigations, extant work indicates that there is indeed correlational evidence 
that smoking is associated with increased risk of panic-related problems among persons 
with a current history of PD and nonclinical panic attacks. These data help to establish an 
association between these factors, but do not elucidate the temporal nature of that 
association, and hence, cannot be used to infer etiological significance.  
In addition to being associated with more severe panic problems, research 
suggests smoking actually increases the risk of panic problems (predisposition models; 
Clark et al., 1994). First, in regard to temporal nature, it is important to note that although 





age 25 (Breslau, Johnson, Hiripi, & Kessler, 2001), the median age of onset for PD is 
typically 24 (Burke et al., 1990). This sequence would indicate that smoking initiation 
generally precedes panic onset. As now will be discussed, outside of this general 
evidence, there are a number of studies that have more specifically examined the 
temporal relations between smoking onset and subsequent risk for panic vulnerability.  
Using data from the Epidemiologic Study of Young Adults and the National 
Comorbidity Survey Tobacco Supplement, Breslau and Klein (1999) found that daily 
smoking increased the risk for the first occurrence of a panic attack or onset of PD, while 
there was no significant risk for panic attacks or PD increasing the risk for smoking. 
Individuals in the Epidemiological Study of Young Adults who were daily smokers and 
had no history of major depression, specifically, were 3.96 times more likely to 
experience a panic attacks than non-smokers (also without a history of major depression). 
There was also a significant difference between the likelihood of experiencing a first 
panic attack among those who continued to smoke and those who quit smoking (Hazard 
Ratios = 4.71 and 0.21, respectively). Results were even more striking among persons 
with PD. After controlling for a history of major depression, daily smokers were 13.13 
times more likely to have PD than non-smokers. Again, the hazard ratio of smoking 
initiation after the onset of PD was not significant. Results from the National 
Comorbidity Study [reported in the same Breslau & Klein (1999) study], although 
somewhat lower, paralleled the results from the Epidemiologic Study of Young Adults. 
In a subsequent study by Breslau, Novak, and Kessler (2004) using the smoking 





past smoking predicted later onset of PD and agoraphobia (Odds Ratios = 2.6 and 4.4, 
respectively, without controlling for comorbid disorders) and that the risk of developing 
these disorders decreased by half with each standard deviation unit of time since quitting. 
Interestingly, neither nicotine dependence nor early onset smoking predicted the first 
onset of psychiatric disorders. However, these studies were cross-sectional and employed 
a unimethod (self-report) assessment protocol. Additionally, the age of onset for both 
daily smoking and psychiatric disorders were assessed through retrospective recall and 
subsequently subject to memory biases. Thus, while these results suggest that smoking 
precedes the onset of panic, the reverse pathway cannot be definitively ruled out. 
Addressing one of the limitations of the Breslau and Klein (1999) and Breslau et 
al. (2004) studies, smoking has been established as a risk factor for PD through several 
prospective studies. Johnson et al. (2000) conducted a longitudinal study examining the 
relation between heavy cigarette smoking (> 20 cigarettes per day) and anxiety disorders 
in adolescents and young adults. Results showed that anxiety disorders during 
adolescence were not significantly related to smoking in young adulthood, however, 
smoking in adolescence increased the risk for developing agoraphobia, GAD, and PD 
during early adulthood. These effects were above the variance accounted for by 
temperament, family history of psychopathology, drug/alcohol use and other 
theoretically-relevant factors. Adolescents who were heavy smokers, specifically, were 
15.58 times more likely to develop PD in early adulthood than non-smokers. 
Interestingly, adolescents who smoked fewer than 20 cigarettes per day were not at 





heavier smoking levels impart greater panic-related risk. There are several interpretive 
caveats to take into consideration with this study. First, assessments were unimethod 
(interviews only) and therefore potentially subject to memory biases, recall distortion, 
and capitalization of method variance. Second, because of low numbers of subjects with 
certain diagnoses (< 10), sub-threshold levels of anxiety disorders were included in the 
analyses making it difficult to fully discern the parameters of the association between 
smoking and clinical levels of panic. 
A second longitudinal study of smoking and panic was conducted in Germany 
over a 4 year period with over 2,500 participants (aged 14-24 years at baseline; Isensee, 
Wittchen, Stein, Höfler, & Lieb, 2003). Similar to Johnson et al. (2000), researchers 
found a unidirectional association between prior smoking and later onset of panic 
attacks/PD. Nicotine dependent smokers had an increased risk of later onset of panic 
attacks. The risk for onset of PD was significant only among those who were nicotine 
dependent smokers at baseline, although this association failed to reach statistical 
significance after controlling for comorbid disorders. However, there was also a 
significant association between panic and later onset of smoking dependence, making the 
temporal relation between smoking and panic unclear. This study is noteworthy for two 
reasons. First, it did not fully replicate the Johnson et al. (2000) study results in terms of 
directionality. Second, it was the first to measure nicotine dependence, rather than 
cigarettes consumed per day, as the primary smoking predictor variable. There are 
important differences between cigarette smoking exposure (cigarettes consumed per day) 





associations with one another (Piper et al., 2004), potentially owing to relatively poor 
conceptualizations of tobacco dependence. However, the Breslau et al. (2004) study 
would indicate that smoking rate rather than nicotine dependence may be the primary 
variable to examine. Future research will need to examine these two variables more 
systematically in order to explicate the role of smoking in regard to panic-related 
problems. 
More recent research has attempted to identify other variables that influence the 
smoking panic association. Zvolensky, Sachs-Ericsson, Feldner, and Schmidt (in press) 
evaluated a moderational model of neuroticism on the association between smoking level 
and panic attacks and panic disorder using data from the National Comorbidity Survey 
(see below for a discussion of moderating variables). Participants (n = 924) included 
current regular smokers, as defined by reporting smoking regularly during the past 
month. Findings indicated that a generalized tendency to experience negative affect 
(neuroticism) moderated the effects of maximum smoking frequency (i.e., number of 
cigarettes smoked per day during the period when smoking the most) on lifetime history 
of panic attacks and panic disorder even after controlling for drug dependence, alcohol 
dependence, major depression and dysthymia, and gender. These effects were remarkably 
specific to panic attacks and panic disorder, as no such moderational effects were 
apparent for other anxiety disorders. It also is noteworthy that the main effects of 
neuroticism and smoking frequency shared very little variance with one another (< 1%). 
This finding is important, as it indicates that these two panic risk factors are tapping 





Finally, McLeish, Zvolensky, Bonn-Miller, and Bernstein (in press) examined the 
moderating role of perceived health in the association between smoking and panic. In a 
sample of daily smokers (n = 220), the interaction between health perceptions and 
smoking rate incrementally predicted anxiety variables, but not depressive symptoms 
even after controlling for alcohol consumption and gender. Furthermore, perceived health 
shared no variance with smoking rate, indicating that these two variables are unique 
factors. These results, in conjunction with Zvolensky, Sachs-Erricson, et. al. (in press), 
suggest individual differences in certain affect variables that enhance emotional reactivity 
or perhaps learning may be relevant to understanding which smokers experience or go on 
to develop panic problems.  
Together, a number of independently replicated investigations have found 
smoking is associated with increased risk for developing panic problems. However, most 
of the investigations are cross-sectional, focus on diagnostic status as a proxy for “panic 
problems,” rather than assess for theoretically-relevant panic processes (e.g., types of 
thinking patterns, behavioral styles), and do not confirm smoking status via biochemical 
verification. Perhaps most importantly, all but two studies have focused on documenting 
a main effect for smoking (see below for an additional example of a moderating effect). 
This research focus made sense given the overall level of knowledge development in the 
area. However, focusing solely on the main effect of smoking, as illustrated by the 
Zvolensky, Sachs-Ericsson et al. (in press) and McLeish et al. (in press) results, may be 
problematic and potentially misleading. To build upon this area of work, we need to 





 As defined by Baron and Kenny (1986) moderating variables are those that affect 
the direction or strength of association between an independent and dependent variable. 
In the present study, a moderator can be usefully conceptualized as a variable that 
influences the association between smoking and panic vulnerability. In contrast, 
mediators (variables that influence the relations between two correlated factors) serve to 
qualify and explicate the nature of the observed co-occurrence. In general,  it is useful to 
conceptualize moderators as a pre-existing individual or environmental characteristic that 
increases or decreases the risk of a certain outcome (e.g., promoting greater panic attacks 
or greater risk of relapse). In contrast, mediators can be usefully conceptualized as factors 
that are “triggered” by the presence of a variable (e.g., smoking) and thereafter serve to 
account for the relation between that variable and an outcome (e.g., panic attacks). 
In moderation, although both the independent and moderator variables may 
significantly predict an outcome variable, it is the interaction between the two that is of 
interest. Thus, moderators help to specify for whom or under what conditions a given risk 
factor like smoking has negative (in this case, panic-related) effects. In short, they help 
psychopathologists identify subpopulations with possibly (but not definitely) different 
causal mechanisms or course of illness. As such, they provide critically important 
information that can be used for highly pragmatic reasons, including guiding intervention 
planning. For example, they might suggest that certain pockets or collections of 
individuals might be the most apt to develop panic-related problems and therefore it may 
make the most sense to focus clinical activities (e.g., implementation of prevention 





 Considering the above mentioned challenges to previous work, we now turn to a 
discussion of potentially moderating variables for smoking in regard to panic 
vulnerability. 
Conceptual Model of Smoking and Panic 
 An emerging pressing question from extant work is: what variables may moderate 
the effects of smoking on panic-related vulnerability? Zvolensky, Schmidt, and Stewart 
(2003) and Zvolensky and Bernstein (2005) have offered an integrative theoretical model 
for better understanding smoking-related effects on panic psychopathology. This model 
specifies a number of different theoretically-relevant pathways for smoking to exert 
negative effects on panic outcomes [e.g., via its effects on physical health functioning, 
direct pharmacological effects, perceived health status, promotion of life stress 
(particularly health-related adverse events and potentially time pressures secondary to 
“integrating” smoking into one’s occupational and personal life), maladaptive coping, 
and withdrawal symptoms] and a number of individual difference and contextual factors 
that can help clarify (or place explanatory parameters on) these pathway specific effects.  
The focus of the present study is on clarifying individual difference characteristics 
that might moderate the effects of smoking on theoretically-relevant panic-related 
processes. Toward this end, there needs to be an attempt to conceptually integrate 
important work on AS and smoking in one overarching model. As briefly discussed 
above, AS is a dispositional, trait-like cognitive characteristic that is unique from the 
temperamental variable of trait anxiety (McNally, 1999b) and is theorized to predispose 





example, if a person perceives bodily sensations that are associated with autonomic 
arousal as a sign of imminent personal harm, this “high anxiety sensitive” individual is 
theorized to experience elevated levels of anxiety and be at an increased risk for a panic 
attack. At least three lines of research have strongly supported this line of theorizing. 
First, prospective studies with adolescents and adults indicate AS predicts the future 
occurrence of panic attacks and worry about the future occurrence of such attacks 
(Schmidt et al., 1997; Weems, Hayward, Killen, & Taylor, 2002). These same 
prospective studies and other cross-sectional investigations indicate AS is relatively 
specific to PD and does not covary with other phenomena distinct from the syndrome 
(e.g., depression; Schmidt, Lerew et al., 1999). Second, AS is a significant predictor of 
responses to panic provocation procedures in the laboratory even after controlling for 
negative affectivity (Zinbarg, Brown, Barlow, & Rapee, 2001); these effects are limited 
to AS Physical Concerns, rather than Mental or Social Concerns. Thus, fear of bodily 
sensations and interoceptive cues are particularly relevant to panic vulnerability. Finally, 
AS is elevated among persons with a history of PD compared to those without the 
disorder (Taylor, Koch, & McNally, 1992). Because AS also decreases with remission of 
panic psychopathology through intervention (Telch et al., 1993), unlike many other panic 
risk factors (e.g., family history of PD, personal history of panic attacks), it can easily be 
targeted for therapeutic change in future prevention work. 
AS may be critically important to PD vulnerability by serving to moderate the 
effect of smoking on the development of panic-related processes (see Figure 1 for a 





ways, including withdrawal symptoms, cardiopulmonary impairment, and respiratory 
irritations, as well as medical diseases (CDC, 2004). In fact, recent research suggests one 
reason for the link between smoking and panic is due to the effects of smoking on 
respiratory function (Caldirola, Bellodi, Cammino, & Perna, 2004). Among persons with 
high levels of AS (particularly Physical Concerns), such interoceptive sensations are 
likely to be experienced as anxiety-provoking. Indeed, AS Physical Concerns has been 
shown to be a significant predictor of fear responding to bodily sensations during 
biological challenge (Brown, Smits, Powers, & Telch, 2003; Carter, Suchday, & Gore, 
2001; Zinbarg et al., 2001; Zvolensky et al., 2002). Specifically, AS may increase the 
likelihood that such interoceptive events will be interpreted as uncontrollable or 
personally threatening, thereby intensifying anxious responding. The high AS Physical 
Concerns individual experiencing bodily sensations related to smoking would therefore 
be exposed to more frequent and intense aversive interoceptive learning trials. In this 
manner, smoking-related cues concerning somatic arousal or other interoceptive 
experiences are more likely to become phobic stimuli (Barlow, 2002). In contrast, 
individuals low in AS Physical Concerns may be less susceptible to the panic-related 
effects of smoking because they are less fearful of bodily sensations. 
In this context, it is important to remember that cues that trigger panic attacks are 
not always immediately obvious to individuals, thus generating the perception that panic 
attacks are “out of the blue.” Additionally, interoceptive cues are typically perceived as 
less predictable than exteroceptive cues (Craske, 1991; Lejuez, Eifert, Zvolensky, & 





interoceptive effects (e.g., withdrawal) may be “predictable” and “expected” for regular 
smokers. However, it is unlikely smokers will always (i.e., on every single occasion) be 
aware of these cues and experience them as “predictable.” Moreover, even expected 
aversive bodily experiences may be potentially panic-relevant events for certain 
individuals. 
Although not the focus of the present study, it is important to note that this 
“affective bind” might place these high-risk persons at risk for smoking as an affect 
management tactic. In fact, numerous lines of evidence support the idea that people, 
including regular smokers, use tobacco as a means of regulating their mood and coping 
with stress, attributing their smoking to its alleged anxiolytic properties (Frith, 1971); 
reliably reporting that they smoke more when stressed or anxious (Shiffman, 1993); and 
holding the expectation that smoking helps reduce negative affect (Copeland, Brandon, & 
Quinn, 1995). Although no single mechanism can presently explain the association 
between smoking and negative affect, a key finding that has emerged from this literature 
is that smoking effects on anxiety-related states are highly dependent on other factors 
related to affective processing (Gilbert & Gilbert, 1998). Specifically, research suggests 
that smoking-related effects on emotional processing are largely indirect and variability 
in response to smoking is strongly affected by individual difference factors (Kassel, 
Stroud, & Paronis, 2003).   
There have only been two tests of the AS-smoking moderator hypothesis in regard 
to panic vulnerability. In one study, the sample was drawn from the population of adult 





epidemiologically-defined (i.e., representative) sample (Zvolensky, Kotov, Antipova, & 
Schmidt, 2003). Results of this cross-sectional study indicated that AS moderated the 
effects of smoking (n = 95 daily smokers from a larger sample of about 400 persons), as 
indexed by cigarettes per day (m = 15 cigarettes per day), in terms of level of 
agoraphobic avoidance; this significant interaction accounted for approximately 10% of 
unique variance after controlling for their respective main effects and the theoretically-
relevant factors of problem alcohol use and negative affectivity. No interaction, however, 
was found for panic attacks, potentially due to the fact that assessment of this factor was 
restricted to the past (most recent) week to enhance the validity of panic reports (but 
probably truncating variability). It also is noteworthy that AS and cigarette smoking were 
not correlated with one another, suggesting that they represent different risk factors for 
panic problems. The second test of the AS-smoking moderator hypothesis was conducted 
with a community sample of adolescents (n = 206; Leen-Feldner, et al., in press). Results 
indicated that after controlling for gender, negative affect, and the main effects of AS and 
smoking rate, AS moderated the effects of smoking status (yes/no) in terms of panic 
attack symptoms (3% variance) and somatic complaints (1% variance), but not 
depression. Specifically, those individuals who were both current smokers and high in AS 
reported the highest rate of panic-related symptoms. As with the Zvolensky, Kotov, et al. 
(2003) study, AS and smoking shared little variance with one another providing further 
support that these two variables represent distinct risk factor for panic problems.  
Overall, these findings suggest smokers are not a homogeneous group in regard to 





enhancing factors) are a key factor in accounting for such differences. However, the 
results are limited in a number of important ways. First, the studies were cross-sectional 
in nature. Second, they relied on self-report and interview methodologies. Third, as with 
earlier studies, smoking status was not confirmed with biochemical assessments. Fourth, 
they focused on the general AS factor, leaving unclear whether or not the observed 
effects were better accounted for by one or more of the specific sub-domains (i.e., AS 
Physical Concerns, but not Mental or Social Concerns). Finally, there was a limited range 
of theoretically-relevant dependent variables and none focused on panic-related 
information processing. 
Present Study  
The overarching purpose of the proposed investigation was to replicate and 
extend past work by testing the moderating role of AS in regard to smoking frequency 
effects on panic vulnerability among a sample of adult regular smokers. Within this 
context, there were two main conceptually related, albeit distinct, domains to investigate: 
one dealing with a cross-sectional test (to broaden past work by identifying associations 
with heretofore undocumented panic-related processes) and the other involving a 
prospective test (to document changes in panic attacks and associations with anticipatory 
anxiety across time). In both cases, the present investigation sought to test the interaction 
between the physical concerns sub-domain of AS and cigarettes per day in regard to 
panic-relevant processes implicated in the aforementioned biopsychosocial model of 
panic disorder etiology (Zvolensky, Schmidt, & Stewart, 2003; Zvolensky & Bernstein, 





to panic vulnerability, as it is a more direct index of “exposure” or “experience” and not 
addiction (i.e., tobacco dependence). That is, it may be a more direct assessment of 
“smoke exposure” and thereby presumably be more likely than tobacco dependence to be 
associated with increased risk of bodily sensations (e.g., via lung impairment). Likewise, 
AS Physical Concerns is the most theoretically-relevant composite for panic vulnerability 
and therefore the focus of the present study. 
In regard to the cross-sectional test, it was expected that after controlling for 
negative affectivity and weekly average alcohol consumption (frequency x quantity 
composite), the interaction between the Physical Concerns subfactor of AS and cigarettes 
per day would be uniquely and significantly predictive of: (1) the tendency to 
catastrophize about bodily sensations (using Agoraphobic Cognitions Questionnaire), (2) 
body vigilance (using Body Vigilance Questionnaire), (3) agoraphobic avoidance [using 
interview-rated pre-morbid (i.e., prior to panic disorder development) agoraphobic 
avoidance behavior via the Panic Disorder Severity Scale], and (4) lifetime history of 
panic attacks (assessed via the SCID-NP [non patient version] panic attack module). 
These hypotheses were premised on previous work documenting an interactive effect of 
AS on smoking outcomes in terms of self-reported agoraphobic avoidance (Zvolensky, 
Schmidt, & McCreary, 2003) and the previously discussed conceptual model which 
suggests through learning experiences with smoking-related interoceptive cues (e.g., 
withdrawal symptoms, lung impairment) smokers with high, but not low, levels of fear of 
bodily sensations will be more apt to focus attention on such events, 





avoidance-oriented affect regulation strategies (including but not limited to smoking) 
because they are perceived as personally “harmful” or “personally threatening.” 2 
In terms of the prospective test, it was expected that after controlling for Time 1 
levels of panic attacks (or anticipatory anxiety in the second analysis), the interaction 
between the Physical Concerns subfactor of AS and cigarettes per day would, within a 3-
month prospective assessment, be uniquely and significantly predictive of: (1) total 
frequency of panic attacks (assessed via the SCID-NP [non patient version] panic attack 
module) and (2) anticipatory anxiety (assessed via the Panic Disorder Severity Scale). 
This model did not use the same covariates as the cross-sectional tests, as the total sample 
size was smaller due to (a) studying only those persons with panic attacks and (b) 
attrition. The second set of hypotheses were attempting to document theoretically-
relevant associations between the AS Physical Concerns and cigarettes per day 
interaction and future-based panic-relevant emotional vulnerability. Overall, it was 
expected that the form of the significant interaction would indicate persons high in AS 
Physical Concerns and average number of cigarettes consumed per day, compared to 
persons scoring low on one or both of these measures, would be more likely to 
experience a panic attack during the three-month follow-up period and exhibit higher 
levels of Time 2 anticipatory anxiety. Although this prospective test naturally was not 
focused on developmental processes per se due to the relatively limited window of time 
allowed in the assessment, it did permit us to chart the degree of variability (with a 





important facet of study at this stage of research development in regard to panic-smoking 
vulnerability processes.  
Method 
Participants 
The sample consisted of 125 daily smokers (60 females; Mage = 26.02 years, SD = 
10.98). Participants were recruited through the University of Vermont using 
advertisements for daily smokers in the campus newspaper and flyers posted on bulletin 
boards located in buildings and commons areas around campus.  Participants also were 
recruited through the general community using newspaper advertisements and flyers 
posted in a local, well-traveled marketplace as well as in local restaurants and bars; 
identical advertisements were used for both the university and community sectors. The 
racial composition of the studied sample generally reflected that of the local population 
(State of Vermont Department of Health, 2000): approximately 95% of the sample was 
Caucasian, 4% African-American, and 1% other. Approximately 10% of the sample had 
at least a 4-year college education, 74% had some college education, 10% had a high 
school degree or the equivalent, and the remaining 6% did not have a high school 
education.  
Participants smoked on average 17.6 cigarettes per day (SD = 8.43), had smoked 
cigarettes regularly for 7.61 (SD = 8.49) years, began cigarette smoking at a mean age of 
13.48 (SD = 2.91) years, and considered themselves regular smokers by a mean age of 
15.79 (SD = 2.8) years. When smoking tobacco the heaviest, participants averaged 24.43 





the Fagerstrom Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, 
& Fagerstrom, 1991), was 3.37 (SD = 2.02); this reflects a low level of overall nicotine 
dependence. Expired carbon monoxide (CO) levels also were evaluated to verify smoking 
status. The average CO level for the current sample was 16.2 ppm (SD = 11.23); scores 
above 8 ppm are considered indicative of regular smoking (please see Smoking Measures 
section for details). 69.6% (n = 87) of the participants were regular alcohol users, 
drinking 5 to 6 alcoholic beverages approximately 2 to 3 times per week.  
Participants reported the following lifetime history of medical problems: 37.6% 
had allergies, 16.8% had experienced some type of head injury, 9.6% had been diagnosed 
with hypertension, 8% had been diagnosed with heart problems, 16% had been diagnosed 
with asthma, 6.4% had some other form of respiratory disease, and 2.4% had epilepsy.  
Participants were administered the Structured Clinical Interview for DSM-IV Axis I 
Disorders- Non-Patient Edition (First, Spitzer, Gibbon, & Williams, 1995) and reported 
the following history of current or past psychiatric problems: 28% had major depressive 
disorder, 25.6% had experienced non-clinical panic attacks, 11.2% had post-traumatic 
stress disorder, 4.8% had generalized anxiety disorder, 4.8% had social phobia, and 2.4% 
had obsessive-compulsive disorder.  
Participants were excluded from the study if they displayed limited mental 
competency or the inability to give informed, written consent. Participants were not 
excluded for medical or psychiatric illness other than panic disorder. Participants with 
panic disorder were excluded from the study, as the aim of the study was to explore 





exclusionary criterion, it would not be possible to ascertain if the AS Physical Concerns 
by smoking rate effects were simply attributable to this condition rather than being a 
potential risk-conferring process.  
Measures 
Time 1 Anxiety-related Measures 
Structured Clinical Interview for DSM-IV Axis I Disorders- Non-Patient Edition 
(SCID-NP). The SCID-NP (First et al., 1995) is a well-established diagnostic interview 
for psychiatric problems, including panic attacks. It assesses Axis I disorders and 
provides a sub-module for panic attacks (including limited symptom attacks). The 
interview was administered in full at Time 1 in order to determine participants’ history of 
psychiatric problems. Reliability ratings by an independent rater (MJZ) were completed 
on a random selection of 20% of the protocols, with no cases of disagreement being 
noted. 
Anxiety Sensitivity Index (ASI). The ASI (Reiss, Peterson, Gursky, & McNally, 
1986) is a 16-item measure that asks respondents to rate on a 5-point Likert scale (0 = 
very little to 4 = very much) the degree to which they fear negative consequences 
stemming from anxiety symptoms. Responses to each item are summed to provide a total 
score from 0-64. Previous research indicates that the ASI is made up of one higher-order 
factor (ASI Total Score) and three lower-order factors: Physical, Psychological, and 
Social Concerns (Zinbarg, Barlow, & Brown, 1997; Stewart, Taylor, & Baker, 1997; 
Rodriguez, Bruce, Pagano, Spencer, & Keller, 2004). The ASI shows adequate test-retest 





score higher than those with other anxiety disorders and those with no disorder), and is 
distinct from trait anxiety (Reiss et al., 1986). The ASI also shows specificity in its 
relation to anxiety but not to depression (Schmidt, Lerew, & Joiner, 1998). Recent 
findings converge on the observation that the Physical Concerns dimension, specifically, 
is most relevant to panic attack vulnerability (Zinbarg et al., 2001; Rodriguez et al., 
2004). Thus, the AS Physical Concerns dimension was employed as a predictor variable 
at Time 1 in the present study.  
Agoraphobic Cognitions Questionnaire (ACQ). The ACQ is a 14-item scale 
measuring thoughts around the negative consequences of experiencing anxiety 
(Chambless, Caputo, Bright, & Gallagher, 1984). Items are rated on a 5-point Likert scale 
from (1) thought never occurs to (5) thought always occurs. The ACQ is comprised of 2 
factors: social/behavioral concerns and physical concerns. The ACQ has been shown to 
have high internal consistency (Cronbach alpha = .87), moderate test-retest reliability (r = 
.67 for one month) and sensitivity to changes due to treatment (Chambless et al., 1984). 
The ACQ can also discriminate clinical from non-clinical groups, especially individuals 
with anxiety disorders (Chambless & Gracely, 1989). The ACQ total score was used to 
index anxiety related cognitions and was administered at Time 1 (a criterion variable). 
Body Vigilance Scale (BVS). The BVS was employed to assess attentional focus 
on somatic symptoms (Schmidt, Lerew, & Trakowski, 1997). The BVS is a 4-item 
instrument in which respondents indicate on an 11-point Likert-type scale (0 = none to 10 
= extreme) the degree to which they agree with a particular statement regarding 





measure attentional focus, perceived sensitivity to changes in body sensations, and the 
average duration of time spent attending to body sensations. A fourth item involves 
having participants rate their attention to 15 body sensations, as defined by the DSM-IV 
physical symptoms for panic attacks. Responses to the fourth item are averaged to yield a 
single score for that item. Summing the four items derives a total score for the BVS. 
Research suggests that the BVS has adequate internal consistency (alpha =.75) and can be 
used to assess changes in bodily attention during cognitive-behavioral treatment for panic 
disorder (Schmidt, Lerew, & Trakowski, 1997). The BVS was administered at Time 1 in 
the present study and served as a primary index of body vigilance. 
Panic Disorder Severity Scale (PDSS). The PDSS is a semi-structured interview 
rating scale for PD (Shear, et al., 1997) that includes ratings of panic frequency and 
intensity, anticipatory anxiety, and avoidance of sensations and situations, and 
impairment in work and social functioning. Each of these symptoms is rated on a 0 
(None) to 4 (Extreme) scale. The PDSS has good psychometric properties (Shear et al., 
1997; Shear et al., 2001). In our lab, two clinicians making PDSS ratings in a dual 
interview were found to have consistently high reliability (Zvolensky, Leen-Feldner et 
al., 2004). In the present investigation, we computed two ratings: (1) anticipatory anxiety 
using the anticipatory anxiety question (item 3) and (2) agoraphobic avoidance using a 
composite of avoidance of situations and avoidance of bodily sensations (items 4 and 5). 
These ratings were examined separately because past work had shown relations of AS by 





2003). Thus, it was important to separate avoidance from other anxiety factors relevant to 
panic vulnerability.  
Positive Affect Negative Affect Schedule (PANAS). The PANAS is a mood 
measure commonly used in psychopathology research (Watson, Clark, & Tellegen, 
1988). It assesses two global dimensions of affect: negative and positive. Only the 
negative affectivity scale (PANAS-NA) was used in this study. A large body of literature 
supports validity of the PANAS (Watson, 2000). For example, the PANAS-NA possess 
good internal consistency (Cronbach’s alpha = .84-.87) and reliability (r = .71) (Watson 
et al., 1988). In the present investigation, the PANAS-NA subscale was employed as a 
covariate.  
Time 1 Smoking-related Measures 
Smoking History Questionnaire (SHQ). Smoking history and pattern was assessed 
with the SHQ, a measure that includes items pertaining to smoking rate, age of onset of 
initiation, years of being a regular smoker, etc. The SHQ has successfully been used in 
previous studies as a measure of smoking history (Brown, Lejuez, Kahler, & Strong, 
2002; Zvolensky, Lejuez, et al., 2004). The SHQ was administered at Time 1 only and 
the average cigarettes per day variable was used as a primary predictor variable. 
Fagerstrom Test for Nicotine Dependence (FTND). The FTND is a six-item scale 
designed to assess gradations in tobacco dependence (Heatherton et al.,1991). The FTND 
is a revision of the Fagerstrom Tolerance Questionnaire (FTQ; Fagerstrom, 1978). The 
FTND has shown good internal consistency, positive relations with key smoking 





McSherry, & Antony, 1994), and high degrees of test-retest reliability (Pomerleau, 
Carton, Lutzke, Flessland, & Pomerleau, 1994). 
Expired Carbon Monoxide. Biochemical verification of smoking status was 
completed by carbon monoxide (CO) analysis of breath samples assessed using a Bedfont 
Micro III Smokerlyzer CO Monitor (Model EC50; Bedfont Scientific USA, Medford, 
NJ). Research indicates that 8 ppm is an optimal cutoff score for reliably discriminating 
smoking status (Jarvis, Tunstall-Pedoe, Feyerabend, Vesey, & Saloojee, 1987). Obtained 
values above this cutoff were considered indicative of smoking at Time 1. 
Alcohol Use Disorders Identification Test (AUDIT). The AUDIT is a 10-item 
screening measure developed by the World Health Organization to identify individuals 
with alcohol problems (Babor, de la Fuente, Saunders, & Grant, 1992). Most items are 
rated on a 5-point Likert scale from (0) never to (4) daily or almost daily. Scores range 
from 0-40 with a score of 8 indicating a likelihood of alcohol use problems. Major areas 
of problematic drinking that are assessed include: alcohol consumption, drinking 
behavior (dependence), adverse psychological reactions, and alcohol-related problems. 
There is a large body of literature attesting to the validity of the AUDIT (Saunders, 
Aasland, Babor, de la Fuente, & Grant, 1993). In the present investigation, we used the 
frequency and quantity items of the AUDIT to index alcohol consumption at Time 1 and 
employed this index as a covariate. 
Time 2 Measures 
 The SCID-NP Panic Attack Module was administered at Time 2 in order to assess 





Severity Scale (PDSS) was re-administered at Time 2 to document change in anticipatory 
anxiety ratings over the 3-month assessment. Only the SCID-NP panic module and PDSS 
were re-administered, rather than all panic-relevant measures, as these were the only two 
factors theorized to possibly show systematic change in the 3-month time period.  
Procedure 
Screening 
 An overview of the entire procedure can be seen in Table 2. Initial screening 
procedures were completed via telephone. Interested individuals were given a brief 
description of the study and asked about smoking status. Potentially eligible participants 
then scheduled an assessment appointment at the Anxiety and Health Research 
Laboratory (AHRL). 
Assessment 
 Upon arrival to the assessment appointment, participants were administered the 
SCID-NP to more thoroughly assess whether or not subjects met inclusion criteria and 
document their psychiatric history as well as the Panic Disorder Severity Scale. After 
completing the interview, smoking status was biochemically verified via CO analysis. 
Subjects then completed the following self-report measures: Anxiety Sensitivity Index, 
Agoraphobic Cognitions Questionnaire, Body Vigilance Scale, Positive and Negative 
Affect Scale, Smoking History Questionnaire, and the Alcohol Use Disorders 
Identification Test (about 90-minutes in total time for session 1). Subjects were then 







During the 3-month prospective phase, reminder calls were placed at 1.5 months 
to keep in touch with participants; specifically, at 1.5 months, we contacted participants 
via telephone to ensure that their contact information had not changed and reminded them 
about the upcoming follow-up assessment. If their phone number had changed or was 
disconnected, we then attempted to contact them via letter. After three months, subjects 
were contacted to schedule their follow-up assessment. Subjects returned to the 
laboratory and were administered the following measures: SCID-NP panic attack module 
and the Panic Disorder Severity Scale. Subjects were then debriefed and given $30 
compensation for their efforts. 
Results 
Statistical Analyses 
The main and interactive effects of smoking rate and AS Physical Concerns for 
the primary dependent variables were evaluated using a hierarchical multiple regression 
(or logistic regression for binary dependent variables) procedure (Cohen & Cohen, 1983). 
For the first set of analyses, separate models were constructed for predicting (1) the 
tendency to catastrophize about bodily sensations (ACQ), (2) body vigilance (BVS), (3) 
agoraphobic avoidance (composite avoidance score from the PDSS), and (4) a lifetime 
history of panic attacks (SCID; this analysis used a logistic regression). Negative 
affectivity and weekly alcohol consumption were entered as covariates at step one in the 
model. At the second step the main effects for smoking rate and AS Physical Concerns 





accounted for by these variables individually. At the third step, the interaction term 
(mean centered) between smoking rate and AS Physical Concerns was entered into the 
model (Baron & Kenny, 1986). 
Hierarchical multiple regression also was employed for the prospective test to 
determine if the interaction between AS Physical Concerns and cigarettes per day at Time 
1 accounted for unique variance in predicting the presence of panic attacks during the 
follow-up period (SCID; logistic regression was employed for this analysis due to the 
binary nature of the dependent variable) and change in anticipatory anxiety at Time 2. 
Separate models were, again, constructed for each of the dependent variables: panic 
attacks and anticipatory anxiety at Time 2. History of panic attacks was entered as a 
covariate at step 1 for the panic attack analysis, and level of anticipatory anxiety at Time 
1 was entered as a covariate for the anticipatory anxiety analysis; this approach allowed 
for an initial test of “change” for each factor, which is consistent with the a priori 
hypotheses. AS Physical Concerns and cigarettes smoked per day at Time 1 were entered 
together at step 2 to evaluate the main effects of these variables. Lastly, the mean 
centered interaction term (AS Physical Concerns x cigarettes per day at time 1) was 
entered at step 3 to test whether AS Physical Concerns at Time 1 moderated the relation 
between smoking history at Time 1 and panic attacks and anticipatory anxiety at Time 2.  
Correlations for Theoretically-Relevant Variables 
 The first step to understand the nature of the data was to compute a series of 
conceptually-relevant zero-order correlations for each of the different assessment time 





association between the primary predictor variables (smoking rate and AS Physical 
Concerns) and the covariates at Time 1. Then, correlations were computed to assess the 
association between the primary predictor variables (smoking rate and AS Physical 
Concerns) and the primary dependent variables at Time 1. Finally, zero-order correlations 
were then computed for primary predictor variables (smoking rate and AS Physical 
Concerns) and the Time 2 dependent measures.  
Associations among predictor variables and covariates at Time 1. Negative 
affectivity was significantly correlated with AS Physical Concerns (r = .67, p < .01), but 
not alcohol consumption (r = .03, p = .70) or smoking rate (r = .14, p = .11). Alcohol 
consumption was significantly correlated with smoking rate (r = -.30, p < .01), but not 
with AS Physical Concerns (r = .02, p = .84). The correlation between smoking rate and 
AS Physical Concerns was minimal (r = -.04, p = .70). 
Associations among predictor and criterion variables at Time 1. Smoking rate 
was significantly associated with lifetime history of panic attacks (r = .19, p < .05), but 
not the tendency to catastrophize about bodily sensations (r = .01, p = .95), body 
vigilance (r = -.08, p = .35), or agoraphobic avoidance (r = .10, p = .28). AS Physical 
Concerns was significantly correlated with the tendency to catastrophize about bodily 
sensations (r = .67, p < .01), body vigilance (r = .62, p < .01), agoraphobic avoidance (r = 
.38, p < .01), and a lifetime history of panic attacks (r = .23. p < .01). The associations 
between the criterion variables were all significant except for the correlation between 





Retention of participants during the follow-up period. 83.2% of the participants (n 
= 104) returned for the Time 2 assessment and were thus included in the Time 2 analyses. 
12% (n = 15) of the participants returning for the second assessment had experienced a 
panic attack during the follow-up period; this is a sizeable percentage, underscoring the 
clinically significant nature of this population, an issue that is returned to in the 
Discussion Section.  
Associations among the covariates, predictor variables and criterion variables at 
Time 2. Lifetime history of panic attacks was significantly correlated with smoking rate (r 
= .19, p < .05) and AS Physical Concerns (r = .23. p < .01). Time 1 anticipatory anxiety 
was significantly associated with AS Physical Concerns (r = .29, p < .01), but not 
smoking rate (r = .09, p = .34). Smoking rate was not significantly associated with the 
presence of panic attacks during the follow-up period (r = .06, p = .56) or Time 2 
anticipatory anxiety (r = .06, p = .56). Similarly, AS Physical Concerns was not 
significantly associated with the presence of panic attacks during the follow-up period (r 
= .10, p = .33) or Time 2 anticipatory anxiety (r = .14, p = .17). 
 Time 1 Regression Equations 
Data for the Time 1 linear regression analyses are presented in Table 4. In terms 
of the tendency to catastrophize about bodily sensations, the first step accounted for 
50.9% of the variance. Negative affectivity was a significant predictor at step 1 of the 
model (t = 10.91, β = .71, p <.01), but alcohol consumption was not (t = -.06, β = -.004, p 
= .95). A significant main effect for AS Physical Concerns was found at step 2 of the 





Contrary to prediction, the interaction between AS Physical Concerns and smoking rate 
did not significantly predict the tendency to catastrophize about bodily sensations (t = 
.70, β = .04, p = .48). 3 
In terms of body vigilance, the first step accounted for 22.4% of the variance. 
Negative affectivity was a significant predictor at step 1 of the model (t = 5.75, β = .47, p 
<.01), but alcohol consumption was not a significant predictor (t = -.42, β = -.03, p = .68). 
A significant main effect for AS Physical Concerns was found at step 2 of the model (t = 
4.98, β = .51, p <.01), but no main effect was observed for smoking rate (t = -1.36, β = -
.11, p = .17). Contrary to prediction, the interaction between AS Physical Concerns and 
smoking rate did not significantly predict body vigilance (t = .47, β = .04, p = .64). 
In terms of agoraphobic avoidance, the first step accounted for 18.3% of the 
variance. Negative affectivity was a significant predictor at step 1 of the model (t = 5.01, 
β = .42, p <.01), but alcohol consumption was not a significant predictor (t = -1.04, β = -
.09, p = .30). There were no main effects for either AS Physical Concerns or smoking rate 
at step 2 of the model (t = .96, β = .11, p = .34 and t = .90, β = .08, p = .37, respectively). 
As hypothesized, the interaction between AS Physical Concerns and smoking rate did 
significantly predict agoraphobic avoidance; the interaction accounted for 3.6% of unique 
variance (t = 2.29, β = .19, p < .05).  
Data for the Time 1 logistic regression is presented in Table 5. In terms of lifetime 
history of panic attacks, negative affectivity (OR = 1.15, p < .01, 95% CI = 1.08-1.22), 
but not alcohol consumption (OR = 1.03, p = .53, 95% CI = .94-1.13), was associated 





Physical Concerns (OR = .96, p = .33, 95% CI = .87-1.05) nor smoking rate (OR = 1.05, 
p = .12, 95% CI = .99-1.11) were associated with a unique change in the odds of having a 
lifetime history of panic attacks above and beyond the covariates. Finally, contrary to 
prediction, the interaction between AS Physical Concerns and smoking rate was not 
related to lifetime history of panic attacks (OR = 1.00, p = .71, 95% CI = .99-1.00). 
Time 2 Regression Equations 
Data for the Time 2 logistic regression analysis is presented in Table 6. In terms 
of the presence of panic attacks during the three-month follow-up period, lifetime history 
of panic attacks (OR = 8.42, p < .01, 95% CI = 2.56-27.68) was associated with a unique 
change in the odds of experiencing a panic attack during the follow-up period. Neither 
AS Physical Concerns (OR = .99, p = .78, 95% CI = .92-1.07) nor smoking rate (OR = 
1.00, p = 1.00, 95% CI = .93-1.07) were associated with a unique change in the odds of 
having panic attacks during the follow-up period above and beyond the covariate. Finally, 
contrary to prediction, the interaction between AS Physical Concerns and smoking rate 
was not related to increased likelihood of experiencing panic attacks during the follow-up 
period (OR = 1.00, p = .86, 95% CI = .99-1.01). 
Data for the Time 2 linear regression analysis is presented in Table 7. In terms of 
anticipatory anxiety at Time 2, Time 1 anticipatory anxiety was not a significant predictor 
at step 1 (t = .28, β = .03, p = .78). There were no main effects for either AS Physical 
Concerns or smoking rate at step 2 of the model (t = 1.38, β = .14, p = .17 and t = .73, β = 





Concerns and smoking rate significantly predicted anticipatory anxiety at Time 2 (t = 
2.32, β = .23, p < .05). 
Graphical Representation of the Statistically Significant Interactions 
Interactions were examined, in regard to hypothesized moderation, to determine 
direction and significance. Statistically significant interactions were examined, in regard 
to hypothesized moderation, both graphically (see Cohen & Cohen, 1983, for a review) 
and analytically (Holmbeck, 2002), to determine direction and conceptual consistency 
with the model. Based on recommendations of Cohen and Cohen (1983; pp. 323, 419), 
the form of significant interactions were examined by inserting specific values for each 
predictor variable into the regression equations associated with the described analysis. 
Specifically, values for each predictor variable at one half of a standard deviation above 
and below the mean for AS Physical Concerns and smoking rate, respectively, were 
inserted into the regression equation and plotted.  
Forms of the interactions supported the hypotheses (please see Figures 2 and 3). 
Among individuals with higher AS Physical Concerns, smoking a greater number of 
cigarettes was associated with higher levels of agoraphobic avoidance at Time 1, whereas 
smoking rate had a relatively weaker association with agoraphobic avoidance across the 
other variable combinations. A similar finding was evident for anticipatory anxiety at 
Time 2. Again, higher levels of AS Physical Concerns and higher rates of daily smoking 
were associated with the greatest elevations in anticipatory anxiety compared to other 
variable combinations. These findings are in accord with the hypothesized effects. 





were conducted on the data to examine moderation.  Results indicated that moderation 
occurred for agoraphobic avoidance but not T2 anticipatory anxiety [t (116) = 4.03, p < 
.01 and t (95) = 1.33, p = .19, respectively]. The association between smoking rate and 
agoraphobic avoidance was moderated when AS Physical Concerns was high.  
Discussion 
 There has been a growing level of clinical interest in better understanding the role 
of smoking and other addictive behaviors in psychiatric conditions in recent years 
(Zvolensky & Schmidt, 2004). This work has grown, at least partially, out of the 
recognition that smoking often co-occurs with psychological problems such as anxiety 
disorders and may be systematically related to the course of such psychopathology. 
Despite the direct clinical and public health importance of addressing such matters, we 
are only at the beginning stages of explicating the nature of smoking-anxiety 
associations. The present study represents an effort to empirically evaluate a cognitive 
vulnerability by smoking model related to panic processes using a cross-sectional and 
prospective measurement protocol.  
Findings from Time 1 Assessment 
 In regard to the cross-sectional analyses, as hypothesized, there was a significant 
interaction between AS Physical Concerns and smoking rate in relation to agoraphobic 
avoidance. These effects were above and beyond the variance accounted for by the 
theoretically-relevant covariates and respective main effects. Inspection of the form of the 
significant interaction was supportive of the theorized AS Physical Concerns by smoking 





Concerns and higher smoking rates, there was a risk for increased agoraphobic 
avoidance. It is noteworthy that the size of the interaction effect was meaningful at 3.6% 
of unique variance (after controlling for the variance accounted for by the covariates and 
main effects; Abelson, 1985). Moreover, such results replicate and extend past work on 
AS and smoking in a Russian epidemiological sample (Zvolensky, Kotov et al., 2003). 
Contrary to prediction, however, the interaction between AS Physical Concerns and 
smoking rate did not significantly predict the tendency to catastrophize about bodily 
sensations, body vigilance, or lifetime history of panic attacks. Thus, three out of the four 
predictions were not supported from an a priori basis.  
 Overall, these Time 1 findings suggest that the interaction between the cognitive 
vulnerability variable of AS and smoking rate is relatively specific to panic-relevant 
avoidance behavior rather than applicable to all aspects of panic vulnerability (e.g., body 
vigilance, catastrophic thinking, and panic attacks). Though cross-sectional in nature, this 
pattern of findings, considered with those of Zvolensky, Kotov et al. (2003), may be used 
to conceptually guide the refinement of etiological models of panic vulnerability that 
involve smoking behavior. For example, rather than smoking rate and AS “combining” to 
confer risk for all aspects of panic vulnerability, perhaps these two risk factors may 
interplay only for certain risk processes like avoidance behavior. Then, once this type of 
maladaptive behavior pattern “emerges,” other panic-relevant processes like anticipatory 
anxiety, vigilance to somatic stimuli, panic attacks, catastrophic thinking, and so on, may 
theoretically “follow.” These types of issues are broadly concerned with “timing” of 





Theory and research on avoidance learning would be broadly consistent with the 
above described type of affect regulation model (cf. self-medication model), whereby 
escape and avoidance responding at Time 1 increased the risk for anxiety symptoms at a 
future time period (Mineka, 1985). The basic premise in such models is that the organism 
learns a contingency between an aversive environmental event and a response pattern that 
serves to avoid contact with it (Zvolensky, Lejuez, & Eifert, 2000). Here, it is interesting 
that these learning processes often can operate beyond conscious awareness. Thus, there 
is an expected disconnect between declarative knowledge about various relevant stimuli 
and the degree of emotional learning that has transpired, particularly during the early 
phases of a conditioning process; a finding supported by a basic research (Bechara et al., 
1995). This type of work may partially explain why there was an observed disconnect 
between self-rated avoidance (presumably, more automatized behavior tied to emotional 
learning) and cognitive factors in the present investigation; that is, between the self-
regulation factor of avoidance and the studied cognitive (presumably, declarative 
knowledge) variables. Of course, given self-rating scales were used to assess both 
avoidance and cognitive factors, these argument is more a theoretical prediction derived 
from extant models to help explain the observed results rather than a complete 
explanation for the observed results. 
Building from such reasoning, as applied conceptually to the present research, it 
may be that a daily smoker learns that certain situations may be evoking uncomfortable 
bodily sensations or anxiety symptoms (theoretically produced, at least partially, by 





situations (“agoraphobic avoidance”). Here, it should be noted that the avoidance 
assessment in the present study was geared toward “classic” general agoraphobic 
situations (e.g., driving). According to the present perspective, however, avoidance could 
be applied to more specific situations/behaviors as well (e.g., smoking to escape/avoid 
escalating negative affect states). That is, there should be great variability in the 
compensatory behaviors to reduce anxiety. As applied to smokers, tests involving 
smoking motives may be a useful way to empirically evaluate such matters with more 
specificity (e.g., AS by smoking rate predicting negative affect reduction smoking 
motives). Additionally, it is important to bear in mind that the cross-sectional 
methodology of the current study cannot differentiate such risk processes from 
concomitants or consequences and thereby does not permit an empirical analysis of these 
precise issues. However, the current results do set the exciting stage for future research to 
follow from this study and empirically evaluate such a model; a perspective that we 
return to in the discussion of the Time 2 analyses (see below).  
 It also is useful to briefly comment on the pattern of zero-order associations 
among predictor and criterion variables at Time 1. Consistent with extant research 
(Breslau & Klein, 1999), smoking rate and history of panic attacks were significantly 
associated with one another. However, smoking rate was not significantly associated with 
any of the panic-relevant process variables. Also, consistent with prior research, AS 
Physical Concerns was significantly positively associated with all of the panic-related 
variables. Furthermore, the association between AS Physical Concerns and smoking rate 





independent risk factors. Of note, alcohol consumption was significantly negatively 
correlated with smoking rate; these two variables are typically positively associated with 
one another (e.g., Strine et al., 2005). This finding is likely due to unique characteristics 
of this sample. Specifically, although this was a primarily young, college-student sample, 
approximately 25% of the sample was from the community (older, community dwelling 
individuals). The demographic characteristics of this subset of the sample were somewhat 
different than those of the primarily college student sample. In particular, the community 
participants reported drinking significantly less, smoking more, were older, and more 
likely to have had drug or alcohol treatment (approximately 50% had a history of 
substance abuse treatment). Thus, there may be unique patterns between community and 
college-based samples in regard to smoking and alcohol use patterns.  
Findings from Time 2 Assessment 
 In regard to the prospective analyses, there was a significant interaction between 
AS Physical Concerns and smoking rate in relation to Time 2 anticipatory anxiety. These 
effects were above and beyond the variance accounted for by the theoretically-relevant 
covariate and respective main effects. Post hoc probing analysis of the form of the 
significant interaction, however, was not supportive of the theorized AS Physical 
Concerns by smoking model of panic-vulnerability. This finding may have been due to 
insufficient power due to the smaller sample size at Time 2. Nonetheless, the size of the 
interaction effect was clinically meaningful at 5% of unique variance (Abelson, 1985). 
Drawing from research in other areas of psychology, prospective studies that follow 





longer follow-up periods (e.g., Rogosa, Brandt, & Zimowski, 1982). Thus, future studies 
using longer follow-up assessments are necessary for sufficient numbers of participants 
to show change in the outcome of interest or that multiple waves of data allow one to 
model change more reliably. Also, contrary to prediction, the interaction between AS 
Physical Concerns and smoking rate did not significantly predict the occurrence of panic 
attacks during the three month follow-up period.  
 Considered with the Time 1 data, the Time 2 results shed further empirical light 
on the nature of the AS Physical Concerns by smoking rate interaction in terms of panic 
vulnerability. Specifically, not only does the interaction between AS Physical Concerns 
and smoking rate concurrently predict agoraphobic avoidance (Time 1 analyses/findings), 
but it also predicts future anticipatory anxiety in a relatively short window of time (Time 
2 analyses/findings). These findings may portend the type of panic-relevant vulnerability 
processes developing among this clinically-relevant daily smoking population. 
Specifically, daily smokers smoking at higher rates with high AS Physical Concerns may 
be more prone to engage in avoidance (Time 1 findings) and show increases in worry 
about potentially threatening events in the future (Time 2 anticipatory anxiety findings). 
One could anticipate that, given any number of adverse events (e.g., exposure to high 
stress situations, unexpected panic attacks), that these individuals (i.e., heavier smokers 
with high AS Physical Concerns) may be more prone than their lower smoking and lower 
AS Physical Concerns counterparts to be more vulnerable to adverse emotional learning 
between interoceptive cues and anxiety states. With more frequent learning experiences, 





together” to potentiate risk for the future development of panic psychopathology. Clearly, 
this type of account, although grounded in empirical observation and conceptual models 
of panic-smoking comorbidity (Zvolensky & Bernstein, 2005), is currently highly 
speculative. It therefore represents an exciting area for future research. The utilization of 
time-sampling or ecological momentary memory assessment methodologies would be 
one way to systematically move this line of inquiry further. 
It also is useful to briefly comment on the pattern of zero-order associations 
among predictor and criterion variables at Time 2. Smoking rate was not significantly 
associated with panic related processes (anticipatory anxiety) or the occurrence of panic 
attacks during the follow up period. In terms of panic attacks, this finding is consistent 
with past research where the association between smoking and future panic attacks was 
only significant among adolescents who smoked greater than 20 cigarettes per day 
(Johnson et al., 2000). Thus, examining these same questions among heavy smokers may 
be useful in isolating the parameters of the smoking rate-panic attack association. The 
lack of association between anticipatory anxiety and smoking rate is consistent with Time 
1 findings and those of Zvolensky, Kotov, et al. (2003) where there was no association 
between smoking rate and anxious arousal symptoms (i.e., the pure, non-overlapping 
symptoms of anxiety compared to depression). Furthermore, AS Physical Concerns also 
was not associated with the Time 2 panic variables, likely due to the limited variability in 
the Time 2 criterion variables. Indeed, case-level data inspection indicated that while 
12% of the Time 2 sample experienced panic attacks during the follow-up period, only 5 






 Results of the current study suggest the potential utility of addressing smoking 
within the context of intervening among individuals at risk for developing panic attacks 
and panic disorder. Specifically, smokers with panic risk factors like AS report using 
smoking as a primary emotion regulation strategy (Zvolensky, Bonn-Miller et al., 2006), 
creating an interconnection between smoking and panic. This interplay creates a situation 
wherein intervention for one problem will ultimately be impaired, or perhaps altogether 
unsuccessful, unless the other problem also is addressed simultaneously. Case reports are 
consistent with this perspective (Zvolensky, Lejuez, Kahler, & Brown, 2003). As one 
illustrative example, when smokers high in cognitive-based risk for panic (e.g., high AS) 
make a smoking cessation attempt, they are (1) at high risk for being emotionally reactive 
to internal cues including, but not limited to, nicotine withdrawal (Zvolensky, Feldner, et 
al., 2005) and (2) “biased” to reduce such distress (avoidant coping), particularly when 
alternative coping strategies are not available. Thus, AS and perhaps other panic-specific 
factors would presumably “prime” motivational processing very early in the quit process. 
In particular, an individual that is highly sensitive to negative affect and other internal 
cues (e.g., high AS) would be apt to smoke, and thereby demonstrate early relapse, to 
ameliorate aversive states elicited by smoking discontinuation. This type of example 
theoretically illustrates the clinically-relevant linkages between panic factors and 
smoking behavior in terms of self-regulation processes and cessation. Similar examples 
could be made in regard to other directional effects; that is, from smoking to panic 





thus not repeated here. In total, if accurate, this forward feeding type of cycle creates the 
need for an integrated intervention that reduces panic problems while considering the role 
of smoking in the larger “psychological context” of therapeutic care. One could imagine 
it would be applicable to not only people at risk for developing panic psychopathology, 
but also smokers with full-blown panic problems. 
Study Limitations and Future Directions 
Although the present study adds to the extant literature on smoking and panic-
relevant variables in a unique manner, there are a number of interpretive caveats that 
deserve further comment.  First, although we used community-based advertisements in 
the recruitment of participants for the present investigation, it is noteworthy that the 
sample was comprised of relatively young adult daily smokers. The sample may have 
been younger, on average, than would be expected from typical community-based 
recruitment due to the fact that advertisements for the study were largely posted in areas 
of the community frequently visited by young adults (e.g., shopping centers, restaurants, 
bars) and therefore may have attracted younger adults to a greater extent than older adult 
smokers.  Second, the sample was comprised of regular (daily), but not heavy, smokers. 
As previous research indicates that the panic-smoking association often is most apparent 
among heavy smokers, it may prove fruitful for future research to examine panic-
vulnerability associations in light, moderate, and heavy smokers. Along these same lines, 
it may be useful to compare panic-vulnerability associations with smoking rate vs. 
nicotine dependence. A comparison of smoking rate and dependence in the prediction of 





of panic disorder etiology by specifying which factor(s) play more formative roles in 
promoting risk. Third, although the sample was representative of the ethnic composition 
of the state of Vermont, it was comprised of predominately Caucasian young adults. To 
improve generalizability of the observed effects, future research could sample from 
locations with more diverse demographic characteristics. Fourth, a three-month follow up 
period is a fairly short period of time. Although we opted to design the present 
investigation for 3-month follow-up to establish precedent for examining these matters 
and assess retention rates among this at-risk population, large changes in 
symptomatology during this specific window of time were not evident. Future studies 
employing longer follow up periods would better document symptom progression.  
Fifth, and somewhat related to the prospective design comment, is that we utilized 
hierarchical linear regression tools for indexing the observed effects. Although a 
reasonable analytic option, these techniques are not as powerful as random regression 
growth curve models and hazard models for modeling change. We used linear regression 
in the present study due to the size of the recruited sample and rather limited focus on one 
interactive process. Building from the present study, it would be advisable to construct 
more powerful tests and use even more sensitive analytic tools for indexing change. 
Sixth, in terms of effect size for the observed significant interactions, meaningful effect 
sizes are being found (e.g., 3% to 5% of variance). However, the clinical significance of 
effects of this size depends on the context in which they are examined. Here, while such 
effect sizes may be a “good start”, they simultaneously underscore that the vast majority 





driven models of risk are critical. Seventh, self-report measures were utilized as the 
primary assessment methodology for many of the key constructs. The utilization of self-
report methods does not fully protect against reporting errors and may be influenced by 
shared method variance. Thus, future studies could build on the present work by utilizing 
laboratory based assessments to provide information about smoking behavior in “real 
time.” For example, evaluating the predictive power of AS by smoking rate in the 
prediction of emotional responsivity to biological challenge would help document 
response patterns across systems. Again, such data could then be used to refine 
theoretical models. Finally, in the broadest “causal model” of panic vulnerability, 
moderators influence the relation between a given risk factor and panic outcomes. The 
present study, grounded in such a heuristic model to guide theoretical predictions, 
addressed one such moderator (AS). However, future work needs to build on the present 
study and address other moderating factors with specified theoretical relevance to the 
overarching panic vulnerability model. Additionally, research should begin to address 
mediators, which theoretically explain the relation between a given risk factor and panic 
psychopathology. This type of work will, as a “system”, begin to lay the groundwork for 
even more advanced tests that attempt to explicate the direction of such processes and 
incorporate multi-variable modeling of effects. 
Conclusions 
 Together, the present findings suggest daily smokers who have higher smoking 
rates and higher levels of AS Physical Concerns report greater agoraphobic avoidance 





of the present findings is that there may be segments of the cigarette smoking population 
who are at relatively greater risk for panic symptoms by virtue of individual differences 
in AS. The identification of such moderating effects is clinically important, as it helps to 
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1Regular cigarette smoking does not necessarily indicate that the individual is 
nicotine dependent. Nicotine dependence implies that the individual meets DSM-IV 
criteria for substance dependence which include symptoms of tolerance, withdrawal, 
inability to cut down or stop use, stopping social, occupational, or recreational activities 
because of substance use, and continued use despite knowledge of having a persistent 
physical or psychological problem because of substance use (APA, 2000). Most studies 
on smoking and PD do not indicate whether or not subjects are nicotine dependent per se. 
In this same context, it is important to note that the term “addiction” will be used instead 
of drug dependence. This is done for several key reasons. Specifically, “dependence” 
does not offer any explanatory meaning over and above “addiction.” Both reflect patterns 
of drug use that impart some cost on the individual; are difficult to stop; typically recur 
after discontinuation; and are characterized, in part, by tolerance and withdrawal. Also, 
by employing the term dependence, confusion at a conceptual level can be created 
because of the more specific term of physical dependence. Physical dependence reflects a 
state in which reduced drug levels elicit withdrawal symptoms. 
2Gender was not included as a covariate in the current study as the sample size did 
not allow for it. Furthermore, there have been no gender effects found in past work or 
theoretical models; thus, there was little reason to examine this factor here. However, 
future research that involves larger sample sizes should address this factor and 





3Due to the overlap between the tendency to misinterpret bodily sensations 
[measured by the Brief Body Sensations Interpretation Questionnaire (BBSIQ)] and the 
tendency to catastrophize about bodily sensations (ACQ), only the results from the ACQ 
are presented here and not for the BBSIQ as originally proposed. The validity of the 
BBSIQ in the current study was questionable as participants consistently had difficulty 
understanding the instructions for completing the BBSIQ despite explanations from the 
research team. Regression analyses were run using the BBSIQ as a criterion variable and 
the interaction between AS Physical Concerns and smoking rate did not significantly 







 Table 1: Key Terms in Risk Factor Research (from Kraemer et al., 1997) 
 
 
Correlate: Two characteristics shown to be associated without any 
implication of a temporal or directional relation.  
 
Risk Factor: A characteristic that has been shown to precede the 
outcome and to be associated with an increase in the 
likelihood of that outcome over base rates in the general 
population. This requires unequivocally demonstrating the 
temporal sequence that entails evidence that the outcome 
was not evident prior to or at the time of the antecedent 
event. 
 
Marker: A risk factor that is not causally involved in the outcome. 
Fixed marker is used to refer to risk factors that are not 
considered malleable; variable marker is used for those risk 
factors that change or can be changed. 
 
Causal Risk Factor: A risk factor that, when altered, has impact on the 
likelihood of the outcome. A causal role of the risk factor in 
the outcome is bolstered by collateral evidence regarding 
the mechanisms involved in the risk-outcome relation. 
Demonstration that an event is a causal risk factor is not 
tantamount to saying that antecedent event is the causal risk 
factor. Inherent in the risk factor approach is the possibility 
that there may be multiple causal risk factors and multiple 










Table 2: Overview of Procedure 
 
Screening 
• Telephone Screening 
• Appointment for assessment set 
Assessment 
• Informed consent 
• Structured Interviews and medical screening 
o SCID-NP 
o Panic Disorder Severity Scale (PDSS) 
• CO analysis 
• Self-report questionnaires 
o Anxiety Sensitivity Index (ASI) 
o Agoraphobic Cognitions Questionnaire (ACQ) 
o Body Vigilance Scale (BVS) 
o Positive and Negative Affect Scale (PANAS) 
o Fagerstrom Test for Nicotine Dependence (FTND) 
o Smoking History Questionnaire (SHQ) 
o Alcohol Use Disorders Identification Test (AUDIT) 
• Compensation 
Follow-Up 
• Interview  
o SCID-NP (panic attack module) 









Table 3: Descriptive Data and Intercorrelations among Predictor and Criterion Variables  
 
 1  2 3 4 5 6 7 8 9 10 11 M SD 
1.  PANAS-NA - .03 .14 .67** .68** .46** .36** .39** .25** .27** .17 21.3 8.46 
2.  Alcohol - - -.30** .02 .00 .00 -.07 .01 -.17 -.05 -.11 6.68 5.36 
3.  Cig/Day - - - -.04 .01 -.08 .10 .19* .09 .06 .06 17.6 8.43 
4.  ASI-PC - - - - .67** .62** .38** .23** .29** .10 .14 11.6 8.28 
5.  ACQ - - - - - .45** .46** .35** .36** .25** .07 1.53 0.49 
6.  BVS - - - - - - .26** .15 .20* .04 .08 16.0 8.28 
7.  T1 Avoidance - - - - - - - .41** .81** .08 -.06 0.21 0.73 
8. T1 Panic Attacks - - - - - - - - .36** .36 .22* - - 
9. T1 AA - - - - - - - - - .03 .03 0.12 0.52 
10. T2 Panic Attacks - - - - - - - - - - .42** - - 
11. T2 AA - - - - - - - - - - - 0.06 0.27 
 
Note. A single asterisk indicates correlation is significant at .05 level; A double asterisk indicates correlation is significant at .01 level; PANAS: 
Positive and Negative Affect Scale- Negative Affectivity subscale (Watson, Clark, & Tellegen, 1988); Alcohol: Weekly Alcohol Consumption; 
Cig/Day: Daily Cigarettes; ASI-PC: Anxiety Sensitivity Index- Physical Concerns subscale (Reiss et al., 1986); ACQ: Agoraphobic Cognitions 
Questionnaire (Chambless et al., 1984); BVS: Body Vigilance Scale (Schmidt, Lerew, & Trakowski, 1997); T1 Avoidance: Agoraphobic 
Avoidance at Time 1 assessed via PDSS (Shear et al., 1997); T1 Panic Attacks: History of panic attacks (yes/no) assessed via SCID-NP (First et 
al., 1995); T1 AA: Anticipatory Anxiety at Time 1 assessed via PDSS (Shear et al., 1997); T2 Panic Attacks: Panic attacks during 3-month 






Table 4: Contribution of the Interaction between AS Physical Concerns and Smoking 
Frequency in Predicting Time 1 Panic-Relevant Variables 
 
     ΔR2 t (each predictor) β   sr2                p  
 
Criterion Variable: Catastrophizing Bodily Sensations 
Step 1     .51         <.01 
   Negative Affectivity   10.91    .71  .50    <.01 
   Alcohol consumption     -.06    .00  .00     ns 
 
Step 2     .05         <.01       
   AS-PC        3.49    .30  .10    <.01   
   Smoking Rate      -.61   -.04  .00     ns 
 
Step 3     .00          ns 
   AS-PC x Smoking Rate         .70    .04  .00     ns    
 
Criterion Variable: Body Vigilance 
Step 1     .22         <.01 
   Negative Affectivity     5.75    .47  .22    <.01 
   Alcohol consumption     -.42   -.03  .00     ns 
 
Step 2     .16         <.01       
   AS-PC         4.98    .51  .18    <.01   
   Smoking Rate     -1.36   -.11  .02     ns 
 
Step 3     .00          ns 
   AS-PC x Smoking Rate          .47    .04  .00     ns    
 
Criterion Variable: Agoraphobic Avoidance 
Step 1     .18         <.01 
   Negative Affectivity     5.01    .42  .18    <.01 
   Alcohol consumption    -1.04   -.09  .01     ns 
 
Step 2     .01          ns       
   AS-PC         .96    .11  .01     ns   
   Smoking Rate        .90    .08  .01     ns 
 
Step 3     .04         <.05    
   AS-PC x Smoking Rate        2.29    .19  .04    <.05    
________________________________________________________________________ 
Note. n = 125; AS-PC = AS Physical Concerns; β = standardized beta weight; sr2 = 




Table 5: Contribution of the Interaction between AS Physical Concerns and Smoking 
Frequency in Predicting Lifetime History of Panic Attacks 
 
 
 Panic Attacks 
Step 1 
     Negative Affectivity 





     AS-PC 





     AS-PC x Smoking Rate 
 
1.00 (.99-1.00) 






Table 6: Contribution of the Interaction between AS Physical Concerns and Smoking 
Frequency in Predicting Time 2 Panic Attacks 
 
 
 Time 2 Panic Attacks 
Step 1 




     AS-PC 





     AS-PC x Smoking Rate 
 
1.00 (.99-1.01) 




Table 7: Contribution of the Interaction between AS Physical Concerns and Smoking 
Frequency in Predicting Time 2 Anticipatory Anxiety 
 
 
     ΔR2 t (each predictor) β   sr2                p  
 
 
Criterion Variable: Time 2 Anticipatory Anxiety 
Step 1     .00          ns 
   T1 Anticipatory Anxiety      .28    .03  .00     ns 
 
Step 2     .02          ns       
   AS-PC         1.38    .14  .02     ns   
   Smoking Rate        .73    .07  .00     ns 
 
Step 3     .05         <.05 
   AS-PC x Smoking Rate        2.32    .23  .05    <.05    
________________________________________________________________________ 
Note. n = 104; AS-PC = AS Physical Concerns; β = standardized beta weight; sr2 = 
squared partial correlation 
Figure 1: Conceptual Model depicting Anxiety Sensitivity Moderating the Effects of 














Figure 2: Time 1 Agoraphobic Avoidance, as indexed by the Panic Disorder Severity 
Scale (Shear et al., 1997), as a function of AS Physical Concerns and number of 
cigarettes smoked per day among participants one-half of a standard deviation above 
































Figure 3: Time 2 Anticipatory Anxiety, as indexed by the Panic Disorder Severity Scale 
(Shear et al., 1997), as a function of AS Physical Concerns and number of cigarettes 
smoked per day among participants one-half of a standard deviation above and/or below 
the mean for each predictor.  
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